Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats

L. Figueroa-Valverde, F. Diaz-Cedillo, M. Lopez-Ramos, E. Garcia-Cervera, E. Pool-Gomez, C. Cardena-Arredondo, G. Ancona-Leon

. 2012 ; 156 (2) : 122-127.

Language English Country Czech Republic

Document type Journal Article

AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additionalAIM was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12039736
003      
CZ-PrNML
005      
20140324112722.0
007      
ta
008      
121217s2012 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.028 $2 doi
035    __
$a (PubMed)22660215
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Figueroa-Valverde, Lauro $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico. lauro_1999@yahoo.com
245    10
$a Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats / $c L. Figueroa-Valverde, F. Diaz-Cedillo, M. Lopez-Ramos, E. Garcia-Cervera, E. Pool-Gomez, C. Cardena-Arredondo, G. Ancona-Leon
520    9
$a AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additionalAIM was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
650    _2
$a alloxan $7 D000496
650    _2
$a zvířata $7 D000818
650    _2
$a krevní glukóza $x metabolismus $7 D001786
650    _2
$a experimentální diabetes mellitus $x krev $7 D003921
650    _2
$a fixní kombinace léků $7 D004338
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glibenklamid $x analogy a deriváty $x farmakokinetika $x terapeutické užití $7 D005905
650    _2
$a hypoglykemika $x farmakokinetika $x metabolismus $7 D007004
650    _2
$a metformin $x terapeutické užití $7 D008687
650    _2
$a pregnenolon $x farmakokinetika $x terapeutické užití $7 D011284
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a tkáňová distribuce $7 D014018
655    _2
$a časopisecké články $7 D016428
700    1_
$a Diaz-Cedillo, Francisco $u Escuela Nacional de Ciencias Biologicas del Instituto Politecnico Nacional. Prol. Carpio y Plan de Ayala s/n Col. Santo Tomas, D.F. C.P. 11340, Mexico
700    1_
$a Lopez-Ramos, Maria $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
700    1_
$a Garcia-Cervera, Elodia $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
700    1_
$a Pool-Gomez, Eduardo $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico
700    1_
$a Cardena-Arredondo, Carlos $u Centro Estatal de Oncologia, Campeche Cam., Mexico
700    1_
$a Ancona-Leon, Graciela $u Laboratorio de Investigacion en Ciencias Biologicas y Farmacoqimica, Facultad de Ciencias Quimico-Biologicas, Universidad Autonoma de Campeche, Av. Agustin Melgar, Col Buenavista C.P.24039 Campeche Cam., Mexico $7 gn_A_00005912
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 156, č. 2 (2012), s. 122-127
856    41
$u http://biomed.papers.upol.cz/magno/bio/2012/mn2.php $y domovská stránka časopisu - plný text volně přístupný = fulltext
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20121217 $b ABA008
991    __
$a 20140324112755 $b ABA008
999    __
$a ok $b bmc $g 963288 $s 797324
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 156 $c 2 $d 122-127 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK138 $a Pubmed-20121217

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...